Evidence map›Paper›PMID 36552913›Full record

ArticleDiagnostics (Basel, Switzerland)2022

Vaginosonography versus MRI in Pre-Treatment Evaluation of Early-Stage Cervical Cancer: An Old Tool for a New Precision Approach?

Ailyn M Vidal Urbinati, Ida Pino, Anna D Iacobone, Davide Radice, Giulia Azzalini, Maria E Guerrieri, Eleonora P Preti, Silvia Martella, Dorella Franchi

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Ailyn M Vidal UrbinatiPreventive Gynecology Unit, European Institute of Oncology IRCCS, 20141 Milan, Italy.ORCID 0000-0001-8656-3098
Ida PinoPreventive Gynecology Unit, European Institute of Oncology IRCCS, 20141 Milan, Italy.
Anna D IacobonePreventive Gynecology Unit, European Institute of Oncology IRCCS, 20141 Milan, Italy.ORCID 0000-0001-6909-1228
Davide RadiceDivision of Epidemiology and Biostatistics, European Institute of Oncology IRCCS, 20141 Milan, Italy.ORCID 0000-0002-5075-1895
Giulia AzzaliniPreventive Gynecology Unit, European Institute of Oncology IRCCS, 20141 Milan, Italy.
Maria E GuerrieriPreventive Gynecology Unit, European Institute of Oncology IRCCS, 20141 Milan, Italy.
Eleonora P PretiPreventive Gynecology Unit, European Institute of Oncology IRCCS, 20141 Milan, Italy.
Silvia MartellaPreventive Gynecology Unit, European Institute of Oncology IRCCS, 20141 Milan, Italy.ORCID 0000-0001-9483-7298
Dorella FranchiPreventive Gynecology Unit, European Institute of Oncology IRCCS, 20141 Milan, Italy.
European Institute of Oncology · ITUniversity of Sassari · ITUniversity of Udine · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aims to analyze the sensitivity of vaginosonography (VGS) and magnetic resonance imaging (MRI) in the preoperative local evaluation of early-stage cervical cancers and to assess their accuracy in the detection of tumors, size of the lesions and stromal invasion by comparing them with the final histopathology report. This single-center study included 56 consecutive patients with cervical cancer who underwent VGS and MRI from November 2012 to January 2021. VGS significantly overestimated the lesion size by 2.7 mm (p = 0.002), and MRI underestimated it by 1.9 mm (p = 0.11). Both MRI and VGS had a good concordance with the pathology report (Cohen’s kappa of 0.73 and 0.81, respectively). However, MRI had a false-negative rate (38.1%) that was greater than VGS (0%) in cases of cervical tumor size <2 cm. We found a good concordance between histology and VGS in the stromal infiltration assessment, with 89% sensitivity (95% CI 0.44−0.83) and 89% specificity (95% CI 0.52−0.86). VGS is a simple, inexpensive, widely available, and fast execution method that can complement ultrasound in particular cases and show a good correlation with MRI in the assessment of tumor dimensions, with a better performance in detecting small tumors (<2 cm).

Indexed as

cervical cancerMRI and gynecological oncology diagnosistransvaginal ultrasoundvaginosonography

Identifiers

PMID36552913
PMCPMC9776852
OpenAlexW4309723645

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.